Company Becton, Dickinson and Company

Equities

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Becton, Dickinson and Company

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 21:00:02 31/05/2024 BST			5-day change	1st Jan Change
232 ^USD	+2.29%		+1.39%	-4.86%

05-15	DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300	MT
05-14	Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows:

- medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.;

- diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.;

- clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc.

Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).

Number of employees: 73,000

USD in Million	2022	Weight	2023	Weight	Delta
Medical 49.1 %	8,841	46.9 %	9,502	49.1 %	+7.48%
Life Sciences 26.5 %	5,564	29.5 %	5,133	26.5 %	-7.75%
Interventional 24.4 %	4,464	23.7 %	4,736	24.4 %	+6.09%

USD in Million	2022	Weight	2023	Weight	Delta
United States 57.4 %	10,722	56.8 %	11,113	57.4 %	+3.65%
EMEA 21.9 %	4,043	21.4 %	4,244	21.9 %	+4.97%
Greater Asia 15.0 %	3,047	16.1 %	2,913	15.0 %	-4.40%
Other 5.7 %	1,058	5.6 %	1,102	5.7 %	+4.16%

Managers	Title	Age	Since
Thomas Polen CEO	Chief Executive Officer	50	31/12/08
Christopher DelOrefice DFI	Director of Finance/CFO	52	05/09/21
Elizabeth McCombs CTO	Chief Tech/Sci/R&D Officer	48	31/12/18
Joseph Smith CTO	Chief Tech/Sci/R&D Officer	-	28/11/21
Denise Fleming CTO	Chief Tech/Sci/R&D Officer	54	30/06/22
Ronald Silverman CTO	Chief Tech/Sci/R&D Officer	54	12-03
Claudia Curtis CMP	Compliance Officer	-	29/02/04
Ami Simunovich IRO	Public Communications Contact	-	31/12/17
Gregory Rodetis IRC	Investor Relations Contact	-	31/12/15
Michelle Quinn LAW	General Counsel	56	31/01/19

Members of the board	Title	Age	Since
Bertram Scott BRD	Director/Board Member	73	23/09/02
Catherine Burzik BRD	Director/Board Member	73	28/01/13
Christopher Jones BRD	Director/Board Member	69	25/07/10
Jeffrey Henderson BRD	Director/Board Member	59	09/08/18
Timothy Ring BRD	Director/Board Member	66	28/12/17
Andy Eckert BRD	Director/Board Member	62	22/09/16
Claire Fraser-Liggett BRD	Director/Board Member	68	19/11/06
Bill Brown BRD	Director/Board Member	61	27/02/22
Thomas Polen CEO	Chief Executive Officer	50	31/12/08
Carrie Byington BRD	Director/Board Member	61	20/10/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	370,594,401	288,100,561 ( 77.74 %)	80,202,608 ( 21.64 %)	77.74 %

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.064 %	26,184,766	9.064 %	6 035 M $
BlackRock Advisors LLC 5.991 %	17,308,299	5.991 %	3 989 M $
STATE STREET CORPORATION 4.684 %	13,530,993	4.684 %	3 119 M $
Eaton Vance Management 3.708 %	10,712,924	3.708 %	2 469 M $
T. Rowe Price International Ltd. 3.503 %	10,120,327	3.503 %	2 333 M $
T. Rowe Price Investment Management, Inc. 2.598 %	7,504,977	2.598 %	1 730 M $
Geode Capital Management LLC 2.088 %	6,030,966	2.088 %	1 390 M $
BlackRock Life Ltd. 1.748 %	5,049,524	1.748 %	1 164 M $
Massachusetts Financial Services Co. 1.668 %	4,817,884	1.668 %	1 110 M $
Wellington Management Co. LLP 1.645 %	4,753,531	1.645 %	1 096 M $

Becton, Dickinson & Co.

1 Becton Drive

07417-1880, Franklin Lakes

+201 847 6800

http://www.bd.com

address Becton, Dickinson and Company(BDX)

Name	Category and Sector
Becton, Dickinson BV Becton, Dickinson BV Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton, Dickinson BV is a Dutch company that manufactures and wholesales medical, surgical & pharmaceutical products. The company is based in Vianen, Netherlands. The CEO of the company is Vincent A. Forlenza.	Medical Specialties
Becton Dickinson India Pvt Ltd.
Becton Dickinson Euro Finance SARL Becton Dickinson Euro Finance SARL Finance/Rental/LeasingFinance Part of Becton, Dickinson & Co., Becton Dickinson Euro Finance SARL is a financing subsidiary/special purpose entity. The company is based in Luxembourg, Luxembourg.	Finance/Rental/Leasing
Employees Retirement Plan of C.R. Bard, Inc. Employees Retirement Plan of C.R. Bard, Inc. Investment ManagersFinance The Employees Retirement Plan of C.R. Bard, Inc. provides retirement benefit services. The private company is located in the US.	Investment Managers
Becton, Dickinson & Co. Master Retirement Trust
Becton Dickinson Luxembourg Finance SARL

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

232 USD

Average target price

278.7 USD

Spread / Average Target

+20.14%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BECTON, DICKINSON AND COMPANY	-4.86%	67.04B
ABBOTT LABORATORIES	-7.16%	178B
MEDTRONIC PLC	-1.23%	107B
DEXCOM, INC.	-4.28%	47.23B
CENCORA, INC.	+10.32%	44.62B
HOYA CORPORATION	+8.14%	42.5B
TERUMO CORPORATION	+15.53%	25.22B
WEST PHARMACEUTICAL SERVICES, INC.	-5.88%	24.14B
ZIMMER BIOMET HOLDINGS, INC.	-5.38%	23.69B
STERIS PLC	+1.38%	22.04B

Other Medical Equipment, Supplies & Distribution